Evidence map›Paper›PMID 29100064›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2017

Outbreak of chikungunya virus in a vulnerable population of Sergipe, Brazil-A molecular and serological survey.

Marielton Dos Passos Cunha, Cliomar Alves Dos Santos, Daniel Ferreira de Lima Neto, Alessandra Soares Schanoski, Shahab Zaki Pour, Saulo Duarte Passos, Mércia Simone Feitosa de Souza, Danuza Duarte Costa, Paolo Marinho de Andrade Zanotto

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Revisiting the emergence of the Chikungunya virus in Alagoas, Northeast of Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marielton Dos Passos CunhaLaboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
Cliomar Alves Dos SantosHealth Foundation Parreiras Horta (FSPH), Central Laboratory of Public Health (LACEN/SE), State Secretary for Health, Sergipe, Brazil.
Daniel Ferreira de Lima NetoLaboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
Alessandra Soares SchanoskiBacteriology Laboratory II, Butantan Institute, São Paulo, Brazil.
Shahab Zaki PourLaboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
Saulo Duarte PassosDepartment of Pediatrics, Jundiaí Medical Faculty, São Paulo, Brazil.
Mércia Simone Feitosa de SouzaCoordination of the Nucleus of Communicable Diseases, State Secretary for Health, Sergipe, Brazil.
Danuza Duarte CostaHealth Foundation Parreiras Horta (FSPH), Central Laboratory of Public Health (LACEN/SE), State Secretary for Health, Sergipe, Brazil.
Paolo Marinho de Andrade ZanottoLaboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil. Electronic address: pzanotto@usp.br.
Universidade de São Paulo · BRFaculdade de Medicina de Jundiaí · BRInstituto Butantan · BR

Funding

Wellcome Trust 107779
6 · The paper itself

Abstract

backgroundChikungunya virus (CHIKV) is a re-emerging arbovirus that is causing outbreaks in several countries of the Americas. The virus was introduced in Brazil in 2014, and since then, several Brazilian states have notified autochthonous cases.

objectivesProvide additional evidence on a CHIKV outbreak and an outline of the laboratory and clinical profile of symptomatic patients in Sergipe, Brazil. STUDY

designIn February 2016, we collected 142 serum samples from symptomatic patients for arboviruses in Sergipe, Brazil. All samples were submitted to qRT-PCR for the emerging arboviruses circulating in Brazil - ZIKV, CHIKV, and DENV - and later submitted to the immunoenzymatic assay. RNA positive samples were randomly selected and sequenced for characterization of the genotype involved in the outbreak.

resultsOur study had 75.35% (107/142) positivity for CHIKV infection, with all age groups and genera being equally infected. The virus was identified in 11 of the 13 cities studied in that state, including the ECSA genotype. Importantly, fever was the only statistically significant symptoms for CHIKV infection (p<0.05), while asthenia was significantly associated with symptomatic patients that were CHIKV-negative (p<0.05).

conclusionsOur findings support the importance of fever as a clinical marker and contribute to molecular and serological surveillance data, which may help in the understanding of CHIKV circulation, emergence and clinical description.

Indexed as

Disease OutbreaksPopulation SurveillanceVulnerable PopulationsAdolescentAdultBrazilChikungunya FeverChikungunya virusChildChild, PreschoolFemaleFeverGenotypeHumansImmunoenzyme TechniquesInfantRNA, ViralChikungunya virusInfectionRe-emerging arbovirus

Identifiers

PMID29100064
PMCPMC7617034
OpenAlexW2766604449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.